The effect of endotracheal administration of N-acetylcysteine and heparin on symptom improvement in acute respiratory distress
Phase 3
Recruiting
- Conditions
- lung disorder.Respiratory disorder, unspecified
- Registration Number
- IRCT20190205042631N1
- Lead Sponsor
- Vice Chancellor of Research and Technology Shahrekord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Patients with acute respiratory distress syndrom and lung cantusion
Exclusion Criteria
Pregnancy
Allergy to heparin or acetylcysteine
Active bleeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of respiratory symptoms. Timepoint: After seven days. Method of measurement: Checklist.
- Secondary Outcome Measures
Name Time Method